Skip to content

geroFarma

Active
Private limited companyfounded 2021active for 5 yearsAlbrecht Rodenbachlaan(Heu) 82, 8501 Kortrijk, BelgiumKBO/BCE: BE 0774.941.908
Summary

geroFarma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €240,699 and a net result of €107,225. Equity is growing by about 67% per year across the filed financial years. Its solvency ranks better than 34% of 12,404 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Financials · financial year 2025, abbreviated format

Equity
€240,699▲ 80.3%
2024 · €133,474
Total assets
€1.1m▲ 8.1%
2024 · €974,039
Net result
€107,225▲ 98.5%
2024 · €54,029
Working capital
€77,695▲ 1,485%
2024 · €4,902
Trend over the years

2022 to 2025, 4 financial years

The operating result has risen three years in a row; 2025 is 81% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.2m 2025 Net result€0.1m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€0.02m-€0.04m▲ 132%€0.1m▲ 125%€0.2m▲ 81.0%
Net result€0.01mwithin the sector's middle half-€0.07mwithin the sector's middle half▲ 440%€0.05mwithin the sector's middle half▼ 18.4%€0.1mabove the sector's middle half▲ 98.5%
Equity€0.01mbelow the sector's middle half-€0.08mbelow the sector's middle half▲ 499%€0.1mwithin the sector's middle half▲ 68.0%€0.2mwithin the sector's middle half▲ 80.3%
Total assets€0.8mwithin the sector's middle half-€1.0mwithin the sector's middle half▲ 18.3%€1.0mwithin the sector's middle half▲ 1.1%€1.1mwithin the sector's middle half▲ 8.1%
Debt€0.8m-€0.9m▲ 10.3%€0.8m▼ 4.9%€0.8m▼ 3.3%
Working capital-€0.1mbelow the sector's middle half-€0.001mbelow the sector's middle half€0.005mbelow the sector's middle half▲ 599%€0.08mwithin the sector's middle half▲ 1,485%
Solvency1.6%below the sector's middle half-8.2%below the sector's middle half▲ 6.6pp13.7%below the sector's middle half▲ 5.5pp22.9%within the sector's middle half▲ 9.2pp
Current ratio0.17below the sector's middle half-1.01below the sector's middle half▲ 0.841.06within the sector's middle half▲ 0.051.78within the sector's middle half▲ 0.72
Return on assets (ROA)1.5%within the sector's middle half-6.9%within the sector's middle half▲ 5.4pp5.5%within the sector's middle half▼ 1.3pp10.2%within the sector's middle half▲ 4.6pp
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.1m
Fixed assets €876,187 ▼ 1.0%
Current assets €176,981 ▲ 99.4%
Equity and liabilities €1.1m
Equity €240,699 ▲ 80.3%
Debt €812,469 ▼ 3.3%
Debt's share of the balance-sheet total falls from 86.3% to 77.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€183,683▲
2024 · €104,734
Cash flow
€116,927▲
2024 · €62,643
Debt to equity
3.38▼
2024 · 6.30
ROE
44.5%▲
2024 · 40.5%
Interest coverage
9.72▲
2024 · 5.39
Debt ≤ 1 year
€99,285▲
2024 · €83,849
Debt > 1 year
€700,800▼
2024 · €751,650
Income taxes
€51,873▲
2024 · €25,614
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.0m€1.1m▲
Fixed assets21/28€0.9m€0.9m▼
Tangible fixed assets22/27€0.04m€0.03m▼
Furniture and vehicles24€0.04m€0.03m▼
Financial fixed assets28€0.8m€0.8m=
Current assets29/58€0.09m€0.2m▲
Amounts receivable within one year40/41€0.07m€0.1m▲
Trade receivables40€0€0.01m▲
Other amounts receivable41€0.07m€0.1m▲
Cash at bank and in hand54/58€0.01m€0.04m▲
Deferred charges and accrued income490/1€0.003m€0.001m▼
Equity and liabilities
Total equity and liabilities10/49€1.0m€1.1m▲
Equity10/15€0.1m€0.2m▲
Contributions10/11€0.001m€0.001m=
Reserves13€0.1m€0.2m▲
Distributable reserves133€0.1m€0.2m▲
Amounts payable17/49€0.8m€0.8m▼
Amounts payable after more than one year17€0.8m€0.7m▼
Financial debts170/4€0.8m€0.7m▼
Amounts payable within one year42/48€0.08m€0.1m▲
Current portion of amounts payable after more than one year42€0.05m€0.05m=
Trade debts44€0-
Suppliers440/4€0-
Taxes, remuneration and social security45€0.02m€0.05m▲
Taxes450/3€0.02m€0.05m▲
Remuneration and social security454/9€0.001m€0.001m=
Other amounts payable47/48€0.01m€284▼
Accrued charges and deferred income492/3€0.005m€0.01m▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.009m€0.01m▲
Other operating charges640/8€0.001m€0.002m▲
Gross operating margin9900€0.1m€0.2m▲
Operating profit (loss)9901€0.1m€0.2m▲
Financial income75/76B€0.003m€0.004m▲
Recurring financial income75€0.003m€0.004m▲
Financial charges65/66B€0.02m€0.02m▼
Recurring financial charges65€0.02m€0.02m▼
Profit (loss) for the period before taxes9903€0.08m€0.2m▲
Income taxes67/77€0.03m€0.05m▲
Profit (loss) for the period9904€0.05m€0.1m▲
Profit (loss) for the period to be appropriated9905€0.05m€0.1m▲
Appropriation of the result
Profit (loss) to be appropriated9906€0.05m€0.1m▲
Transfer to equity691/2€0.05m€0.1m▲
To other reserves6921€0.05m€0.1m▲

The notes to these accounts (18 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€788€0€8,615€9,702▲ 12.6%
Other operating charges640/8€295€771€749€1,513▲ 102%
Gross operating margin9900€19,492€43,427€105,483€185,196▲ 75.6%
Operating profit (loss)9901€18,409€42,656€96,119€173,980▲ 81.0%
Financial income75/76B-€50,000€2,955€4,006▲ 35.6%
Recurring financial income75-€50,000€2,955€4,006▲ 35.6%
Financial charges65/66B€49€11,400€19,431€18,889▼ 2.8%
Recurring financial charges65€49€11,400€19,431€18,889▼ 2.8%
Profit (loss) for the period before taxes9903€18,360€81,256€79,643€159,098▲ 99.8%
Income taxes67/77€6,103€15,068€25,614€51,873▲ 103%
Profit (loss) for the period9904€12,257€66,188€54,029€107,225▲ 98.5%
Profit (loss) for the period to be appropriated9905€12,257€66,188€54,029€107,225▲ 98.5%
Line2022202320242025Change
Assets
Total assets20/58€0.8m€1.0m€1.0m€1.1m▲ 8.1%
Fixed assets21/28€0.8m€0.8m€0.9m€0.9m▼ 1.0%
Tangible fixed assets22/27--€0.04m€0.03m▼ 23.1%
Furniture and vehicles24--€0.04m€0.03m▼ 23.1%
Financial fixed assets28€0.8m€0.8m€0.8m€0.8m=
Current assets29/58€0.02m€0.1m€0.09m€0.2m▲ 99.4%
Amounts receivable within one year40/41-€0.1m€0.07m€0.1m▲ 79.8%
Trade receivables40-€0.007m€0€0.01m-
Other amounts receivable41-€0.1m€0.07m€0.1m▲ 62.5%
Cash at bank and in hand54/58€0.02m€0.01m€0.01m€0.04m▲ 284%
Deferred charges and accrued income490/1€54€33€0.003m€0.001m▼ 80.8%
Equity and liabilities
Total equity and liabilities10/49€0.8m€1.0m€1.0m€1.1m▲ 8.1%
Equity10/15€0.01m€0.08m€0.1m€0.2m▲ 80.3%
Contributions10/11€0.001m€0.001m€0.001m€0.001m=
Reserves13€0.01m€0.08m€0.1m€0.2m▲ 80.9%
Distributable reserves133€0.01m€0.08m€0.1m€0.2m▲ 80.9%
Amounts payable17/49€0.8m€0.9m€0.8m€0.8m▼ 3.3%
Amounts payable after more than one year17€0.7m€0.8m€0.8m€0.7m▼ 6.8%
Financial debts170/4€0.7m€0.8m€0.8m€0.7m▼ 6.8%
Amounts payable within one year42/48€0.1m€0.1m€0.08m€0.1m▲ 18.4%
Current portion of amounts payable after more than one year42€0.04m€0.04m€0.05m€0.05m=
Trade debts44€0.001m€0.001m€0--
Suppliers440/4€0.001m€0.001m€0--
Taxes, remuneration and social security45€0.006m€0.02m€0.02m€0.05m▲ 167%
Taxes450/3€0.006m€0.01m€0.02m€0.05m▲ 180%
Remuneration and social security454/9-€0.001m€0.001m€0.001m=
Other amounts payable47/48€0.1m€0.06m€0.01m€284▼ 98.1%
Accrued charges and deferred income492/3-€0.004m€0.005m€0.01m▲ 144%
Line2022202320242025Change
Profit (loss) for the period9904€12,257€66,188€54,029€107,225▲ 98.5%
+ Depreciation and write-downs630€788€0€8,615€9,702▲ 12.6%
Operating cash flow (approximation)€13,045€66,188€62,643€116,927▲ 86.7%
Investment in fixed assets (approximation)--€55,588-€48,314-€602▲ 98.8%
Change in cash--€14,129€389€31,130▲ 7,904%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
31-12-2025 abbreviated format 11-07-2026 2026-00291413
31-12-2024 abbreviated format 11-07-2025 2025-00261336
31-12-2023 abbreviated format 17-07-2024 2024-00258794
31-12-2022 abbreviated format 24-07-2023 2023-00262487

Similar companies · same sector, comparable size

Of the 5,203 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,876. 3,542 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Subsidies and aid

Flemish government

2022 · 1 entry · €90 awarded · €90 paid
Schemes
1 entry · €90 · €90 paid · Fonds voor Innoveren en Ondernemen

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.